Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aurinia Pharmaceuticals

8.59
-0.0550-0.64%
Volume:1.25M
Turnover:10.96M
Market Cap:1.16B
PE:32.27
High:8.86
Open:8.67
Low:8.56
Close:8.64
Loading ...

Major Investment Alert: Kevin Tang Boosts Stake in Aurinia Pharmaceuticals

TIPRANKS
·
05 Mar

Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock?

Zacks
·
05 Mar

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Simply Wall St.
·
02 Mar

Stock Track | Aurinia Pharmaceuticals Soars 5% as 2024 Earnings Beat Expectations

Stock Track
·
01 Mar

RBC Lowers Price Target on Aurinia Pharmaceuticals to $8 From $9, Keeps Outperform, Speculative Risk

MT Newswires Live
·
28 Feb

Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
28 Feb

Aurinia Pharmaceuticals Inc (AUPH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
28 Feb

Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals

TIPRANKS
·
28 Feb

Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth

TIPRANKS
·
28 Feb

Aurinia Pharmaceuticals Reports Balanced Earnings with Growth and Challenges

TIPRANKS
·
28 Feb

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations

Benzinga
·
28 Feb

Stock Track | Aurinia Pharmaceuticals Plummets 13.46% as Q4 Earnings and Guidance Disappoint Investors

Stock Track
·
27 Feb

Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Aurinia Pharmaceuticals Swings to Q4 Earnings, Revenue Rises

MT Newswires Live
·
27 Feb

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates

Zacks
·
27 Feb

Aurinia Pharmaceuticals Files Form 8-K Indicating Key Corporate Event

TIPRANKS
·
27 Feb

Aurinia: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q4 EPS $0.01, vs. FactSet Est of $0.02 Loss

MT Newswires Live
·
27 Feb

Aurinia Pharmaceuticals Q4 2024 GAAP EPS $0.01 Beats $(0.02) Estimate, Sales $59.87M Miss $59.94M Estimate

Benzinga
·
27 Feb

BRIEF-Aurinia Pharmaceuticals Q4 Pretax Profit USD 1.173 Million

Reuters
·
27 Feb